Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. van den Hoogen F, et al. Among authors: van laar jm. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682 Free article.
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.
Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, Czirják L, Denton CP, Distler O, Furst DE, Gabrielli A, Herrick A, Inanc M, Kahaleh B, Kowal-Bielecka O, Medsger TA Jr, Mueller-Ladner U, Riemekasten G, Sierakowski S, Valentini G, Veale D, Vonk MC, Walker U, Chung L, Clements PJ, Collier DH, Csuka ME, Jimenez S, Merkel PA, Seibold JR, Silver R, Steen V, Tyndall A, Matucci-Cerinic M, Pope JE, Khanna D. Fransen J, et al. Among authors: van den hoogen f. Arthritis Care Res (Hoboken). 2012 Mar;64(3):351-7. doi: 10.1002/acr.20679. Arthritis Care Res (Hoboken). 2012. PMID: 22052558 Free PMC article.
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. van den Hoogen F, et al. Among authors: van laar jm. Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3. Arthritis Rheum. 2013. PMID: 24122180 Free PMC article.
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.
Johnson SR, Naden RP, Fransen J, van den Hoogen F, Pope JE, Baron M, Tyndall A, Matucci-Cerinic M, Denton CP, Distler O, Gabrielli A, van Laar JM, Mayes M, Steen V, Seibold JR, Clements P, Medsger TA Jr, Carreira PE, Riemekasten G, Chung L, Fessler BJ, Merkel PA, Silver R, Varga J, Allanore Y, Mueller-Ladner U, Vonk MC, Walker UA, Cappelli S, Khanna D. Johnson SR, et al. Among authors: van den hoogen f, van laar jm. J Clin Epidemiol. 2014 Jun;67(6):706-14. doi: 10.1016/j.jclinepi.2013.12.009. Epub 2014 Apr 8. J Clin Epidemiol. 2014. PMID: 24721558 Free PMC article.
Specificity of Systemic Sclerosis Classification Criteria.
Baron M, Pope JE, Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Matucci-Cerinic M. Baron M, et al. Among authors: van den hoogen f. J Rheumatol. 2015 Dec;42(12):2512. doi: 10.3899/jrheum.150694. J Rheumatol. 2015. PMID: 26628709 No abstract available.
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Among authors: van den hoogen f, van laar jm. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets.
Nevskaya T, Pope JE, Turk MA, Shu J, Marquardt A, van den Hoogen F, Khanna D, Fransen J, Matucci-Cerinic M, Baron M, Denton CP, Johnson SR. Nevskaya T, et al. Among authors: van den hoogen f. J Rheumatol. 2021 Nov;48(11):1698-1717. doi: 10.3899/jrheum.201594. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993109 Free PMC article.
Validation of potential classification criteria for systemic sclerosis.
Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE. Johnson SR, et al. Among authors: van den hoogen f. Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67. doi: 10.1002/acr.20684. Arthritis Care Res (Hoboken). 2012. PMID: 22052658 Free PMC article.
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
Alizadeh BZ, Broen J, Rueda B, Hesselstrand R, Wuttge D, Simeon C, Ortego-Centeno N, Gonzalez-Gay MA, Pros A, Herrick A, Worthington J, Denton C, Fonseca C, Riemekasten G, Vonk MC, van den Hoogen F, Guiducci S, Matucci-Cerinic M, Scorza R, Beretta L, Airó P, Coenen M, Martin J, Koeleman BP, Radstake TR; EUSTAR. Alizadeh BZ, et al. Among authors: van den hoogen f. J Rheumatol. 2010 Aug 1;37(8):1673-9. doi: 10.3899/jrheum.091259. Epub 2010 Jun 15. J Rheumatol. 2010. PMID: 20551103
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.
Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ; SPIN Investigators. Kwakkenbos L, et al. Among authors: van den hoogen f. Rheumatology (Oxford). 2017 Aug 1;56(8):1302-1311. doi: 10.1093/rheumatology/kex055. Rheumatology (Oxford). 2017. PMID: 28431140 Free PMC article.
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.
Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD; SPIN Investigators. Dougherty DH, et al. Among authors: van den hoogen f. Rheumatology (Oxford). 2018 Sep 1;57(9):1623-1631. doi: 10.1093/rheumatology/key139. Rheumatology (Oxford). 2018. PMID: 29868924 Clinical Trial.
The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.
Radstake TR, Vonk MC, Dekkers M, Schijvenaars MM, Treppichio WL, Lafyatis R, Riemekasten G, van den Hoogen F, Coenen MJ. Radstake TR, et al. Among authors: van den hoogen f. Hum Immunol. 2009 Feb;70(2):130-3. doi: 10.1016/j.humimm.2008.10.012. Epub 2008 Nov 24. Hum Immunol. 2009. PMID: 19032966
Systemic sclerosis: state of the art on clinical practice guidelines.
Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M. Smith V, et al. Among authors: van den hoogen f, van vollenhoven r, van laar jm. RMD Open. 2018 Oct 18;4(Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. eCollection 2018. RMD Open. 2018. PMID: 30402270 Free PMC article.
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Merkel PA, Silliman NP, Denton CP, Furst DE, Khanna D, Emery P, Hsu VM, Streisand JB, Polisson RP, Akesson A, Coppock J, van den Hoogen F, Herrick A, Mayes MD, Veale D, Seibold JR, Black CM, Korn JH; CAT-192 Research Group; Scleroderma Clinical Trials Consortium. Merkel PA, et al. Among authors: van den hoogen f. Arthritis Rheum. 2008 May 15;59(5):699-705. doi: 10.1002/art.23564. Arthritis Rheum. 2008. PMID: 18438905 Free PMC article. Clinical Trial.
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.
Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ. Kwakkenbos L, et al. Among authors: van den hoogen f. Rheumatology (Oxford). 2023 Nov 2;62(11):3771. doi: 10.1093/rheumatology/kez234. Rheumatology (Oxford). 2023. PMID: 31168593 Free PMC article. No abstract available.
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group. van Laar JM, et al. Among authors: van den hoogen fh, van de loosdrecht aa. JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368. JAMA. 2014. PMID: 25058083 Free article. Clinical Trial.
Unraveling SSc Pathophysiology; The Myofibroblast.
van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P. van Caam A, et al. Among authors: van lent p, van den hoogen f, van der kraan p. Front Immunol. 2018 Nov 13;9:2452. doi: 10.3389/fimmu.2018.02452. eCollection 2018. Front Immunol. 2018. PMID: 30483246 Free PMC article. Review.
Mortality in systemic sclerosis: an international meta-analysis of individual patient data.
Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Ioannidis JP, et al. Among authors: van den hoogen f, van laar jm. Am J Med. 2005 Jan;118(1):2-10. doi: 10.1016/j.amjmed.2004.04.031. Am J Med. 2005. PMID: 15639201
Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.
Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, van den Hoogen F, Hoogendijk J, Höweler C, de Jager A, Jennekens F, Koehler P, van der Leeuw H, de Visser M, Verschuuren JJ, Wintzen AR. Badrising UA, et al. Among authors: van doorn p, van den hoogen f, van engelen b, van der leeuw h, van duinen sg. Neurology. 2000 Nov 14;55(9):1385-7. doi: 10.1212/wnl.55.9.1385. Neurology. 2000. PMID: 11087787
Short fatigue questionnaire: Screening for severe fatigue.
Penson A, van Deuren S, Worm-Smeitink M, Bronkhorst E, van den Hoogen FHJ, van Engelen BGM, Peters M, Bleijenberg G, Vercoulen JH, Blijlevens N, van Dulmen-den Broeder E, Loonen J, Knoop H. Penson A, et al. J Psychosom Res. 2020 Aug 28;137:110229. doi: 10.1016/j.jpsychores.2020.110229. Online ahead of print. J Psychosom Res. 2020. PMID: 32890861 Free article.
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.
den Broeder N, Verhoef L, de Man YA, Kok MR, Thurlings R, van der Weele W, van den Bemt BJ, van den Hoogen FH, van der Maas A, den Broeder AA. den Broeder N, et al. Among authors: van den hoogen fh. RMD Open. 2024 Apr 9;10(2):e003659. doi: 10.1136/rmdopen-2023-003659. RMD Open. 2024. PMID: 38599654 Free PMC article.
Efficacy of methylprednisolone in very early systemic sclerosis: results of the "Hit hard and early'' randomized controlled trial.
Kersten BE, Lemmers JMJ, Vanhaecke A, Velauthapillai A, van den Hombergh WMT, van den Hoogen FHJ, van den Ende CHM, Smith V, Vonk MC. Kersten BE, et al. Among authors: van den hoogen fhj. Rheumatology (Oxford). 2024 Mar 29:keae156. doi: 10.1093/rheumatology/keae156. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38552324
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.
van Hal TW, van den Reek JMPA, Wenink MH, Otero ME, Ossenkoppele PM, Njoo MD, Oostveen A, Peters B, Tjioe M, Kop EN, Körver JEM, Dodemont SRP, Kleinpenning MM, Berends MAM, Veldkamp WR, van Doorn MBA, Mommers JM, Lindhout RJ, Kuijpers ALA, van Lümig PP, de Jonge CEJ, Tupker RA, Hendricksen J, Keijsers RR, van den Hoogen FHJ, Vriezekolk JE, de Jong EMGJ. van Hal TW, et al. Among authors: van den hoogen fhj. J Dermatolog Treat. 2024 Dec;35(1):2304025. doi: 10.1080/09546634.2024.2304025. Epub 2024 Jan 23. J Dermatolog Treat. 2024. PMID: 38263716 Free article.
Virtues in Competency-Based Assessment Frameworks: A Text Analysis.
Verstegen PMB, Kole JJJ, Groenewoud AS, van den Hoogen FJA. Verstegen PMB, et al. Among authors: van den hoogen fja. Perspect Med Educ. 2023 Oct 19;12(1):418-426. doi: 10.5334/pme.996. eCollection 2023. Perspect Med Educ. 2023. PMID: 37868074 Free PMC article.
Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study.
Lemmers JM, van Caam AP, Kersten B, van den Ende CH, Knaapen H, van Dijk AP, Hagmolen Of Ten Have W, van den Hoogen FH, Koenen H, van Leuven SI, Alkema W, Smeets RL, Vonk MC. Lemmers JM, et al. Among authors: van den hoogen fh. J Scleroderma Relat Disord. 2023 Oct;8(3):221-230. doi: 10.1177/23971983231175213. Epub 2023 May 22. J Scleroderma Relat Disord. 2023. PMID: 37744051 Free PMC article.
Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA. Michielsens C, et al. Among authors: van den hoogen f. Scand J Rheumatol. 2024 May;53(3):180-187. doi: 10.1080/03009742.2023.2213509. Epub 2023 Jun 20. Scand J Rheumatol. 2024. PMID: 37339375
Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort.
Van Hal TW, Mulder MLM, Wenink MH, Van den Hoogen FHJ, Maurits JSF, Pasch MC, Van den Reek JMPA, De Jong EMGJ. Van Hal TW, et al. Among authors: van den reek jmpa, van den hoogen fhj. Acta Derm Venereol. 2023 Apr 27;103:adv5269. doi: 10.2340/actadv.v103.5269. Acta Derm Venereol. 2023. PMID: 37186169 Free PMC article.
Patient involvement in basic rheumatology research at Nijmegen: a three year's responsive evaluation of added value, pitfalls and conditions for success.
de Wit MPT, Koenders MI, Neijland Y, van den Hoogen FHJ, van der Kraan PM, van de Loo FAJ, Berkers H, Lieon M, van Caam A, van den Ende C. de Wit MPT, et al. Among authors: van der kraan pm, van de loo faj, van den hoogen fhj, van den ende c, van caam a. BMC Rheumatol. 2022 Oct 7;6(1):66. doi: 10.1186/s41927-022-00296-6. BMC Rheumatol. 2022. PMID: 36203190 Free PMC article.
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial.
Michielsens CA, den Broeder N, van den Hoogen FH, Mahler EA, Teerenstra S, van der Heijde D, Verhoef LM, den Broeder AA. Michielsens CA, et al. Ann Rheum Dis. 2022 Oct;81(10):1392-1399. doi: 10.1136/annrheumdis-2022-222260. Epub 2022 Jun 14. Ann Rheum Dis. 2022. PMID: 35701155 Clinical Trial.
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial.
Mulder MLM, Vriezekolk JE, van Hal TW, Nieboer LM, den Broeder N, de Jong EMGJ, den Broeder AA, van den Hoogen FHJ, Helliwell PS, Wenink MH. Mulder MLM, et al. Lancet Rheumatol. 2022 Apr;4(4):e252-e261. doi: 10.1016/S2665-9913(22)00028-5. Epub 2022 Feb 28. Lancet Rheumatol. 2022. PMID: 38288921
430 results